BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 33217868)

  • 1. Association of elevated inflammatory markers and severe COVID-19: A meta-analysis.
    Ji P; Zhu J; Zhong Z; Li H; Pang J; Li B; Zhang J
    Medicine (Baltimore); 2020 Nov; 99(47):e23315. PubMed ID: 33217868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
    Elshazli RM; Toraih EA; Elgaml A; El-Mowafy M; El-Mesery M; Amin MN; Hussein MH; Killackey MT; Fawzy MS; Kandil E
    PLoS One; 2020; 15(8):e0238160. PubMed ID: 32822430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of severe cases with COVID-19: a meta-analysis.
    Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
    Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
    Henry BM; de Oliveira MHS; Benoit S; Plebani M; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1021-1028. PubMed ID: 32286245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review.
    Henry BM; Benoit SW; de Oliveira MHS; Hsieh WC; Benoit J; Ballout RA; Plebani M; Lippi G
    Clin Biochem; 2020 Jul; 81():1-8. PubMed ID: 32473151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
    Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
    J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses.
    Borges do Nascimento IJ; von Groote TC; O'Mathúna DP; Abdulazeem HM; Henderson C; Jayarajah U; Weerasekara I; Poklepovic Pericic T; Klapproth HEG; Puljak L; Cacic N; Zakarija-Grkovic I; Guimarães SMM; Atallah AN; Bragazzi NL; Marcolino MS; Marusic A; Jeroncic A;
    PLoS One; 2020; 15(9):e0239235. PubMed ID: 32941548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of inflammatory markers with the severity of COVID-19: A meta-analysis.
    Zeng F; Huang Y; Guo Y; Yin M; Chen X; Xiao L; Deng G
    Int J Infect Dis; 2020 Jul; 96():467-474. PubMed ID: 32425643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory findings of COVID-19: a systematic review and meta-analysis.
    Zhang ZL; Hou YL; Li DT; Li FZ
    Scand J Clin Lab Invest; 2020 Oct; 80(6):441-447. PubMed ID: 32449374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we predict the severity of coronavirus disease 2019 with a routine blood test?
    Zeng F; Li L; Zeng J; Deng Y; Huang H; Chen B; Deng G
    Pol Arch Intern Med; 2020 May; 130(5):400-406. PubMed ID: 32356642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.
    Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A
    Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 16. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.
    Huang I; Pranata R; Lim MA; Oehadian A; Alisjahbana B
    Ther Adv Respir Dis; 2020; 14():1753466620937175. PubMed ID: 32615866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus.
    Renieris G; Katrini K; Damoulari C; Akinosoglou K; Psarrakis C; Kyriakopoulou M; Dimopoulos G; Lada M; Koufargyris P; Giamarellos-Bourboulis EJ
    Shock; 2020 Nov; 54(5):633-637. PubMed ID: 32433216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver damage at admission is an independent prognostic factor for COVID-19.
    Chen LY; Chu HK; Bai T; Tu SJ; Wei Y; Li ZL; Hu LL; Zhu R; Zhang L; Han CQ; Xiao L; He Q; Song J; Liu WH; Zhu QJ; Chen H; Yang L; Hou XH
    J Dig Dis; 2020 Sep; 21(9):512-518. PubMed ID: 32713118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications.
    An PJ; Zhu YZ; Yang LP
    Pharmacol Res; 2020 Sep; 159():104946. PubMed ID: 32450346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis.
    Zhao K; Li R; Wu X; Zhao Y; Wang T; Zheng Z; Zeng S; Ding X; Nie H
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2279-2287. PubMed ID: 32651736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.